Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002029 · ClinicalTrials.gov registry record · NA
Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002029 is a NA study that has completed, run by Abbott.
The verdict
NCT00002029, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare two lipid emulsions in the long-term parenteral alimentation of patients with AIDS in relation to: Clinical effectiveness. Effect on immunologic function. Effect on HIV load as measured by p24 antigen levels. Effect on relative HIV infectivity.
Interventions
- DRUG Fat Emulsion 2%
- DRUG Fat Emulsion 20%
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002029
The ClinicalTrials.gov registry entry for NCT00002029 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fat Emulsion 2% is the first listed.
NCT00002029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002029 about?
NCT00002029 is a clinical study titled "Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent". To compare two lipid emulsions in the long-term parenteral alimentation of patients with AIDS in relation to: Clinical effectiveness. Effect on immunologic function. Effect on HIV load as measured by p24 antigen levels. Effect on relative HIV infectivity.
What is the current status of trial NCT00002029?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002029?
The interventions under investigation include: Fat Emulsion 2% (DRUG), Fat Emulsion 20% (DRUG).
Who is sponsoring clinical trial NCT00002029?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.